Vifor Pharma sheds finished drug manufacturing biz days after $11.7B sale to CSLnews2021-12-16T14:42:22+00:00December 16th, 2021|Fierce Pharma|
Vifor Pharma sheds finished drug manufacturing biz days after $11.7B sale to CSLnews2021-12-16T14:42:22+00:00December 16th, 2021|Fierce Pharma|
A view to brevity: Brand Institute’s clear-eyed approach to naming AbbVie’s new eyesight drug Vuitynews2021-12-16T14:21:37+00:00December 16th, 2021|Fierce Pharma|
A view to brevity: Brand Institute’s clear-eyed approach to naming AbbVie’s new eyesight drug Vuitynews2021-12-16T14:21:37+00:00December 16th, 2021|Fierce Pharma|
Novartis launches $15B share buyback after huge windfall from Roche stake sale—but M&A is still in the cardsnews2021-12-16T14:08:38+00:00December 16th, 2021|Fierce Pharma|
Novartis launches $15B share buyback after huge windfall from Roche stake sale—but M&A is still in the cardsnews2021-12-16T14:08:38+00:00December 16th, 2021|Fierce Pharma|
Lonza teams with Agilent with aim to transform cell therapy manufacturingnews2021-12-16T13:44:23+00:00December 16th, 2021|Fierce Pharma|
Lonza teams with Agilent with aim to transform cell therapy manufacturingnews2021-12-16T13:44:23+00:00December 16th, 2021|Fierce Pharma|
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 2026news2021-12-16T09:30:10+00:00December 16th, 2021|Fierce Pharma|
As part of $800M investment, Pfizer opens gene therapy facility in NC for early-stage productionnews2021-12-16T06:52:02+00:00December 16th, 2021|Fierce Pharma|
